1. Home
  2. ADVM vs ACNT Comparison

ADVM vs ACNT Comparison

Compare ADVM & ACNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADVM
  • ACNT
  • Stock Information
  • Founded
  • ADVM 2006
  • ACNT 1945
  • Country
  • ADVM United States
  • ACNT United States
  • Employees
  • ADVM N/A
  • ACNT N/A
  • Industry
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • ACNT Steel/Iron Ore
  • Sector
  • ADVM Health Care
  • ACNT Industrials
  • Exchange
  • ADVM Nasdaq
  • ACNT Nasdaq
  • Market Cap
  • ADVM 94.6M
  • ACNT 111.9M
  • IPO Year
  • ADVM 2014
  • ACNT N/A
  • Fundamental
  • Price
  • ADVM $4.32
  • ACNT $11.97
  • Analyst Decision
  • ADVM Buy
  • ACNT
  • Analyst Count
  • ADVM 5
  • ACNT 0
  • Target Price
  • ADVM $16.60
  • ACNT N/A
  • AVG Volume (30 Days)
  • ADVM 1.0M
  • ACNT 76.8K
  • Earning Date
  • ADVM 11-07-2025
  • ACNT 11-04-2025
  • Dividend Yield
  • ADVM N/A
  • ACNT N/A
  • EPS Growth
  • ADVM N/A
  • ACNT N/A
  • EPS
  • ADVM N/A
  • ACNT N/A
  • Revenue
  • ADVM $1,000,000.00
  • ACNT $172,594,000.00
  • Revenue This Year
  • ADVM $1,449.40
  • ACNT $22.72
  • Revenue Next Year
  • ADVM N/A
  • ACNT N/A
  • P/E Ratio
  • ADVM N/A
  • ACNT N/A
  • Revenue Growth
  • ADVM N/A
  • ACNT 33.04
  • 52 Week Low
  • ADVM $1.78
  • ACNT $9.17
  • 52 Week High
  • ADVM $8.18
  • ACNT $13.70
  • Technical
  • Relative Strength Index (RSI)
  • ADVM 50.91
  • ACNT 42.40
  • Support Level
  • ADVM $4.18
  • ACNT $11.86
  • Resistance Level
  • ADVM $4.34
  • ACNT $12.26
  • Average True Range (ATR)
  • ADVM 0.26
  • ACNT 0.25
  • MACD
  • ADVM -0.05
  • ACNT -0.00
  • Stochastic Oscillator
  • ADVM 40.96
  • ACNT 16.36

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

About ACNT Ascent Industries Co.

Ascent Industries Co is engaged in the chemical and metal industry. The group operates into two reportable segments namely the Specialty Chemicals and Tubular Products. The Tubular Products segment serves markets through pipe and tube and customers in the appliance, architectural, automotive, and commercial transportation, brewery, chemical, petrochemical, and other industries. The Specialty Chemicals segment produces specialty products for pulp and paper, coatings, adhesives, sealants, and elastomers (CASE), textile, automotive, household, and other industries. It manufactures welded pipe and tube, majorly from stainless steel, duplex, and nickel alloys. The company also produces specialty chemicals and dyes used in various end markets.

Share on Social Networks: